PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • Drexel University
  • National Institute of Allergy and Infectious Diseases (R21AI133372)
  • Juvenile Diabetes Research Foundation United States of America (1-PNF-2018-658-A-N)
  • Directorate for Engineering (1839505)
  • CURE Childhood Cancer
  • Pennsylvania Department of Health
  • National Science Foundation
  • Oregon Clinical and Translational Research Institute

This publication has 59 references indexed in Scilit: